Short Call | An overall slowdown for pharma or just pockets of distress? TVS Motor, HUL, SBI Life in focus
Much like Nifty companies, pharma giants are now facing a slowdown in earnings growth. After enjoying a joyride through FY24, posting record revenues quarter after quarter, several pharma companies ...
pharmaphorum6d
Boehringer's blockbuster Spiriva under pressure, profits down
In a question and answer session at the company's annual results conference in Germany today, managing director Hubertus von Baumbach noted that Spiriva's patent had expired in the US. But he said ...
pharmaphorum1d
Boosted by new drugs, Boehringer shrugs off patent expiry
Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO. Formerly the company's chief finance officer, Hubertus von Baumbach has been in ...
Medscape1d
The Asthma–Chronic Obstructive Pulmonary Disease Overlap Syndrome
The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...
Medscape1d
Advances in Airway Clearance Technologies for Chronic Obstructive Pulmonary Disease
Expert Rev Resp Med. 2013;7(6):673-685. Airflow increases as it passes through a vessel of decreasing diameter. The total cross-sectional area of the airways decreases from the peripheries toward ...